News

US FDA issues warning letter to Alkem's Daman unit

19-Nov-2026 | 15:05

 Alkem Laboratories announced that the US FDA has issued a warning letter dated November 18, 2026 for Company's manufacturing facility located at Amaliya, Daman. The Company shall be responding to the US FDA within stipulated timeline.

The Company continues to manufacture and supply approved products from the said facility to the U.S. market.

Previously, the US FDA had conducted inspection of the this facility from 20 April  2026 to 01 May 2026. The US FDA had classified the inspection status of the said facility as Official Action Indicated (OAI).